U.S. Markets open in 8 hrs 8 mins

Can the Rally in Osiris (OSIR) Shares Continue?

Zacks Equity Research

As of late, it has definitely been a great time to be an investor in Osiris Therapeutics, Inc. (OSIR). The stock has moved higher by 28.6% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider OSIR’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as OSIR has earned itself a Zacks Rank #1 (Strong Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.

OSIRIS THERAPEUTICS MD (OSIR): Free Stock Analysis Report

Zacks Investment Research